awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q38201750-208BA06C-E79B-46B8-9DB7-39EEE6A69E8C
Q38201750-208BA06C-E79B-46B8-9DB7-39EEE6A69E8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38201750-208BA06C-E79B-46B8-9DB7-39EEE6A69E8C
Headaches in brain tumor patients: primary or secondary?
P2860
Q38201750-208BA06C-E79B-46B8-9DB7-39EEE6A69E8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38201750-208BA06C-E79B-46B8-9DB7-39EEE6A69E8C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8e83ba8e8dac3073e164e1c9d1e3e6a861260009
P2860
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas.